Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD22-targeted CAR-T immunotherapy
Welcome,
Profile
Billing
Logout
Companies
Products
Products
Diseases
Trials
News
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Products
0
1
2
3
4
5
6
7
8
9
10
SZGIMI
Avalon GloboCare
Beijing Boren Hospital
National Cancer Institute
Cellectis
Kecellitics Biotech
Legend Biotech
Shanghai Unicar
Autolus
IASO BIO
Miltenyi Biotec
Seattle Children's Hospital
Shanghai Yake Biotech
Shenzhen BinDeBio
Academy of Military Medical Sciences
Adaptive Biotech
AstraZeneca
BMS
Baylor College of Medicine
BioNTech
Chongqing Precision Biotech
Fundamenta Therap
Gracell
Hrain Biotech
Juventas Cell Therapy
KK Women's and Children's Hospital
Medical College of Wisconsin
Nanjing Bioheng Biotech
National University Hospital Singapore
Novartis
Novatim Immune Therap
PersonGen Biomedicine
Shanghai Public Health Clinical Center
Shanghai Ultra-T Immune Therap
Shenzhen University General Hospital
Singapore General Hospital
Stanford University
The First Affiliated Hospital of Soochow University
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James)
UT MD Anderson Cancer Center
University of Colorado
University of Pennsylvania
Wuhan Bio–Raid
Xuzhou Medical University
